Bio-Works Technologies AB (publ) (NGM:BIOWKS)
Sweden
· Delayed Price · Currency is SEK 1.295
-0.035 (-2.63%)
At close: May 12, 2025
Bio-Works Technologies AB Revenue
In the year 2024, Bio-Works Technologies AB had annual revenue of 30.49M SEK, down -30.55%. Bio-Works Technologies AB had revenue of 7.67M in the quarter ending December 31, 2024, a decrease of -49.10%.
Revenue
30.49M
Revenue Growth
-30.55%
P/S Ratio
3.21
Revenue / Employee
1.02M
Employees
30
Market Cap
97.84M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 30.49M | -13.41M | -30.55% |
| Dec 31, 2023 | 43.90M | 2.58M | 6.23% |
| Dec 31, 2022 | 41.32M | -15.04M | -26.68% |
| Dec 31, 2021 | 56.36M | 49.13M | 679.08% |
| Dec 31, 2020 | 7.23M | 1.66M | 29.83% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Camurus AB | 1.87B |
| Medicover AB | 23.56B |
| AddLife AB | 10.42B |
| Vitrolife AB | 3.61B |
| Vimian Group AB | 4.24B |